And the negative correlation between 6 ICD-related genes (CD8A, PRF1, IFNG, CXCR3, TNF, CD8B) and risk score and the protective function of these 6 genes in SKCM indicates that drugs targeting these genes may be a novel treatment method in melanoma. This evidence concerns the gene CD8B and melanoma.